Iron Metabolism Protein – Function and Importance

What Are Iron Metabolism Proteins?

Iron metabolism proteins are a group of proteins that collectively control the absorption, transport, storage, and utilization of iron in the human body. Iron is an essential trace element required for the production of hemoglobin – the oxygen-carrying protein in red blood cells – and for a wide range of enzymatic processes. Because excess iron is cytotoxic, its levels must be tightly regulated by a network of specialized proteins.

Key Iron Metabolism Proteins

Transferrin

Transferrin is the primary iron transport protein in the bloodstream. It binds ferric iron ions (Fe³⁺) and carries them to target tissues, mainly the bone marrow for erythropoiesis and the liver for storage. Reduced transferrin saturation is a key indicator of iron deficiency.

Ferritin

Ferritin is the main intracellular iron storage protein. It is capable of sequestering up to 4,500 iron atoms in a non-toxic, bioavailable form. Serum ferritin levels are widely used as a clinical marker: low values indicate iron deficiency, while elevated values may suggest inflammation, iron overload, or certain underlying conditions.

Hepcidin

Hepcidin is a peptide hormone produced primarily by the liver and is considered the master regulator of systemic iron homeostasis. It acts by inhibiting ferroportin, the only known cellular iron export channel, thereby blocking the release of iron from intestinal cells, macrophages, and hepatocytes into the circulation. Elevated hepcidin levels during chronic inflammation can result in functional iron deficiency anemia.

Ferroportin

Ferroportin is the sole known iron export protein found on the surface of cells. It is expressed predominantly in duodenal enterocytes, macrophages, and hepatocytes and is responsible for releasing iron into the bloodstream. Mutations in the ferroportin gene can cause rare forms of hereditary hemochromatosis.

DMT1 (Divalent Metal Transporter 1)

DMT1 is a membrane transporter that facilitates the uptake of non-heme iron (Fe²⁺) from the intestinal lumen into enterocytes. It plays a central role in intestinal iron absorption and is also involved in intracellular iron trafficking following receptor-mediated endocytosis.

IRP1 and IRP2 (Iron Regulatory Proteins)

IRP1 and IRP2 are intracellular sensor proteins that regulate iron metabolism at the cellular level. Under low-iron conditions, they bind to specific RNA structures known as Iron Response Elements (IREs), thereby modulating the translation or stability of mRNAs encoding transferrin receptor, ferritin, and other iron-related proteins.

Clinical Relevance

Dysregulation of iron metabolism proteins is associated with a range of clinically significant conditions:

• Iron deficiency anemia: The most common form of anemia worldwide, resulting from insufficient iron intake, absorption, or increased demand.
• Hereditary hemochromatosis: A genetic disorder of iron overload, most commonly caused by mutations in the HFE gene affecting hepcidin regulation.
• Anemia of chronic disease: Elevated hepcidin levels in response to chronic inflammation lead to functional iron restriction despite adequate body iron stores.
• Sideroblastic anemia: A disorder characterized by impaired iron utilization in developing red blood cells.

Diagnosis and Laboratory Parameters

Assessment of iron metabolism typically involves a panel of laboratory tests:

• Serum ferritin: Reflects total body iron stores
• Serum iron: Measures the amount of circulating iron bound to transferrin
• Transferrin saturation: The percentage of transferrin binding sites occupied by iron
• Soluble transferrin receptor (sTfR): A marker of tissue iron demand
• Hepcidin levels: May be measured in the context of specific iron disorders

Therapeutic Approaches

Treatment depends on the underlying disorder. Iron deficiency is addressed with oral or intravenous iron supplementation. In cases of iron overload such as hereditary hemochromatosis, regular therapeutic phlebotomy is the standard of care. In selected patients, chelation therapy – using agents that bind and remove excess iron – may be employed. Emerging therapeutic strategies aim to modulate the hepcidin-ferroportin axis to treat both iron deficiency and iron overload conditions.

References

1. Ganz T. - Systemic iron homeostasis. Physiological Reviews, 2013; 93(4):1721-1741. PubMed PMID: 24137020.
2. Andrews N.C. - Disorders of iron metabolism. New England Journal of Medicine, 1999; 341(26):1986-1995.
3. World Health Organization (WHO) - Iron deficiency anaemia: assessment, prevention and control. WHO/NHD/01.3, Geneva 2001.